Stay updated on Safety of Single Dose UB-221 in Urticaria Clinical Trial

Sign up to get notified when there's something new on the Safety of Single Dose UB-221 in Urticaria Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of Single Dose UB-221 in Urticaria Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Footer updates: added 'Revision: v3.3.3' and removed 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T13:37:28.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    The page revision updated from v3.2.0 to v3.3.2, and no study content or critical details were altered. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T17:54:41.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Removed the site-wide notice about government funding lapse and potential delays in processing. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-17T17:45:54.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The updated page preserves the same study details and sections (overview, eligibility, interventions, outcomes, and contacts). Only layout and visual elements appear updated, with no changes to core content.
    Difference
    0.4%
    Check dated 2025-11-03T12:30:02.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Summary of changes: added a government funding notice with current operating status guidance and updated version to v3.2.0; removed the old version label v3.1.0.
    Difference
    5%
    Check dated 2025-10-05T17:28:38.000Z thumbnail image
  9. Check
    99 days ago
    Change Detected
    Summary
    - Updated revision from v3.0.2 to v3.1.0. - Added phone contact: 886-3-668-4800 ext 3201.
    Difference
    0.1%
    Check dated 2025-09-28T10:43:36.000Z thumbnail image

Stay in the know with updates to Safety of Single Dose UB-221 in Urticaria Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of Single Dose UB-221 in Urticaria Clinical Trial page.